glutathione and glutamate cysteine ligase cyn SYNTHESIS Covalent Targeting of Glutamate Cysteine

108 WallaceD

Results with decitabine, a hypomethylating agent in the treatment of chronic myelogenous leukemia (CML) in accelerated or blastic phases

Clinically, higher CD36 expression correlated with the luminal androgen receptor (LAR) subtype of TNBC, known to exhibit a higher sensitivity to ferroptosis

*Correspondence: Isabelle Boileau, [email protected] These authors have contributed equally to this work This article was submitted to Neuroimaging, a section of the journal Frontiers in Psychiatry Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers